BrainChip Research Enter into a Research Collaboration with Biotome for SARS-CoV-2 Antibody Detection

BrainChip Research Enter into a Research Collaboration with Biotome for SARS-CoV-2 Antibody Detection
on April 06 2021 9:00 AM
PERTH, Australia--(BUSINESS WIRE)--BrainChip Holdings Ltd (ASX: BRN), a leading provider of ultra-low power high performance artificial intelligence technology, today announced that the Brainchip Research Institute in Perth has entered into a research collaboration with precision immunology company Biotome Pty Ltd. Biotome is developing highly accurate antibody tests for infections.
The Akida neuromorphic processor chip will be used to interpret sensor responses and to find out which responses are the most representative for antibodies that are protective. The objective of the Biotome research project is to create a handheld device that uses nanomaterial-based sensors in combination with the Akida chip that will give accurate results in seconds.

Related Keywords

Perth ,Western Australia ,Australia ,Akida Nso ,Brainchip Akida ,Biotome Linkedin ,Samuel Lundin ,Brainchip Holdings Ltd ,Ai Edge Network ,Brainchip Research Institute ,Smart Health ,Brainchip Ltd ,Biotome Pty Ltd ,Biotome Pty ,Artificial Intelligence ,Smart Home ,Smart City ,பெர்த் ,மேற்கு ஆஸ்திரேலியா ,ஆஸ்திரேலியா ,சாமுவேல் லுண்டின் ,ஐ விளிம்பு வலைப்பின்னல் ,புத்திசாலி ஆரோக்கியம் ,செயற்கை உளவுத்துறை ,புத்திசாலி வீடு ,புத்திசாலி நகரம் ,